Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

November 15, 2024 - Balanced Wellness, a trusted provider of holistic mental health services, has announced the expansion of ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and ...

Autism is a complex interplay of symptoms that extend far beyond the diagnostic labels commonly associated with mental health conditions. From mood dysregulation and attentional challenges to trauma ...

Demand for mental health services exceeds available resources globally, and access to diagnosis and evidence-based treatment ...

From diagnosis and treatment selection to rehabilitation and survivorship, a patient’s journey requires close attention.

This roundup offers a look at the latest insights from the clinicians and researchers investigating chronic obstructive pulmonary disease and asthma.

AI in healthcare is causing a revolution in how clinicians document, analyze, and make decisions. Two key breakthroughs ...

WALTHAM, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced ...

Mauro highlighted the need for a balanced approach, integrating both real-world data and clinical trial evidence to optimize ...

There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

Last revised in 2015, the document provides guidance for addressing underdiagnosis and undermanagement of the disease, as ...